DeFloria Receives FDA Clearance for Phase 2 Cannabinoid Drug Development

If you cannot view this email, please click here.

Balancing Root Zone pH in Cannabis Cultivation

Understanding how water quality, substrates and fertilizers impact substrate pH is crucial to crop health.

DeFloria Achieves Ground-Breaking Milestone in Botanical Drug Development

In ‘huge first,’ systemically absorbed oral cannabinoid AJA001 from Charlotte’s Web genetics receives FDA clearance for Phase 2 clinical trials.

World Leaders Vote to Ban HHC, List as Schedule II Drug

The UN Commission on Narcotic Drugs approved a recommendation to include the cannabinoid in the 1971 Convention on Psychotropic Substances.

Meet the 2025 Best Cannabis Companies to Work For

The sixth annual ‘Best Cannabis Companies’ program recognizes organizations that stand out for their ongoing efforts to create great places to work.

SNDL Reports Q4 and Full Year 2024 Financial and Operational Results

Wana Brands Brings Hemp-Derived THC Edibles to Texas

Trulieve Opening Medical Cannabis Dispensary in North Miami Beach

Idaho Lawmakers Introduce Cannabis Legalization Bill Days After Passing Resolution to Block Voters’ Powers

New Mexico Bill Aims to Provide Health Insurance for Medical Cannabis Advances

About CBT:
Cannabis Business Times is the most trusted source of actionable intelligence for plant-touching cannabis businesses throughout North America.

P.O. Box 186, Hainesport, NJ 08036

To unsubscribe from Cannabis Business Times' email newsletter click here.